Micoxolamina

Ciclopirox Olamine, the active ingredient in Micoxolamina, is an antifungal presented as a vaginal formulation for local use. It treats vulvovaginal candidiasis and other vaginal fungal infections in adult women. The medication is applied intravaginally and works directly at the site of infection, providing targeted therapy with minimal systemic absorption.

GNH USA supplies Micoxolamina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Micoxolamina, a vaginal antifungal, is used to treat fungal infections of the vaginal mucosa. - Vulvovaginal candidiasis: reduces fungal load and alleviates symptoms such as itching, burning, and discharge. - Other vaginal fungal infections: eradicates non‑candidal yeasts and molds, restoring normal vaginal flora. - Recurrent vaginal fungal infection prophylaxis: may be used as a maintenance regimen to prevent recurrence in susceptible individuals.

Micoxolamina may cause local and systemic adverse reactions, most of which are mild, reversible, and limited to the application site.

Common Side Effects: - Vaginal irritation: mild burning or stinging at the application site. - Itching: localized pruritus in the vaginal area. - Discharge: increased vaginal discharge or spotting. - Odor change: temporary alteration in vaginal odor.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Contact dermatitis: intense inflammation of the vaginal mucosa. - Stevens‑Johnson syndrome: rare but life‑threatening skin reaction.

Before using Micoxolamina, consider the following precautions to ensure safe and effective therapy. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician; use only if benefits outweigh risks. - Allergy: avoid if known hypersensitivity to ciclopirox olamine or any excipients. - Concomitant vaginal products: do not use simultaneously with other intravaginal medications or douches. - Severe mucosal irritation: discontinue if intense irritation or ulceration develops. - Store at room temperature: keep in the original packaging, protect from moisture and direct light.

Micoxolamina can interact with other agents; awareness of major and moderate interactions helps prevent adverse effects.

Major Interactions (Avoid): - Concurrent use of spermicidal agents: may increase local irritation. - Combination with other topical antifungals (e.g., azoles): risk of additive irritation. - Use with systemic antifungal therapy (e.g., fluconazole): may alter local drug absorption.

Moderate Interactions (Monitor Closely): - Vaginal douches or cleansers: can reduce drug efficacy. - Hormonal contraceptives: no direct interaction, but monitor for any changes in vaginal environment. - Lubricants containing irritants: may exacerbate local side effects.